| J9271 | Injection, pembrolizumab, 1 mg | 4,400 | $40 | $189.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 520 | $100 | $52.6K |
| J0897 | Injection, denosumab, 1 mg | 2,760 | $20 | $52.4K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 560 | $70 | $37.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 200 | $120 | $23.2K |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 50 | $340 | $18.1K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 18,000 | $1 | $18K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 70 | $150 | $9.7K |
| 99222 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 80 | $110 | $8.3K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 130 | $60 | $7.3K |